Blank C - Search Results

1

Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.

Bex A, Van der Veldt AA, Blank C, Meijerink MR, Boven E, Haanen JB. Bex A, et al. Among authors: blank c. Acta Oncol. 2010 May;49(4):520-3. doi: 10.3109/02841860903521111. Acta Oncol. 2010. PMID: 20105087 No abstract available.

2

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J. Bex A, et al. Among authors: blank c. World J Urol. 2009 Aug;27(4):533-9. doi: 10.1007/s00345-008-0368-7. Epub 2009 Jan 15. World J Urol. 2009. PMID: 19145434

3

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.

Powles T, Kayani I, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boletti K, Sadev A, O'Brien T, Berney D, Beltran L, Haanen J, Bex A. Powles T, et al. Among authors: blank c. Ann Oncol. 2011 May;22(5):1041-1047. doi: 10.1093/annonc/mdq564. Epub 2011 Jan 17. Ann Oncol. 2011. PMID: 21242586 Free PMC article. Clinical Trial.

4

Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.

Bex A, Larkin J, Blank C. Bex A, et al. Among authors: blank c. Curr Oncol Rep. 2011 Jun;13(3):240-8. doi: 10.1007/s11912-011-0159-y. Curr Oncol Rep. 2011. PMID: 21298371 Review.

5

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.

Powles T, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boleti E, Sahdev A, O'Brien T, Berney D, Beltran L, Nathan P, Haanen J, Bex A. Powles T, et al. Among authors: blank c. Eur Urol. 2011 Sep;60(3):448-54. doi: 10.1016/j.eururo.2011.05.028. Epub 2011 May 17. Eur Urol. 2011. PMID: 21612860

6

A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ.

Bex A, Blank C, Meinhardt W, van Tinteren H, Horenblas S, Haanen J. Bex A, et al. Among authors: blank c. Urology. 2011 Oct;78(4):832-7. doi: 10.1016/j.urology.2011.05.034. Epub 2011 Jul 29. Urology. 2011. PMID: 21802123 Clinical Trial.

7

Combination of targeted therapy and immunotherapy in melanoma.

Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Free PMC article. Review.

8

Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.

Vogel WV, Guislain A, Kvistborg P, Schumacher TN, Haanen JB, Blank CU. Vogel WV, et al. J Clin Oncol. 2012 Jan 10;30(2):e7-e10. doi: 10.1200/JCO.2011.37.9693. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124094 No abstract available.

9

Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response?

Bex A, Etto T, Vyth-Dreese F, Blank C, Griffioen AW. Bex A, et al. Among authors: blank c. Curr Oncol Rep. 2012 Jun;14(3):230-9. doi: 10.1007/s11912-012-0229-9. Curr Oncol Rep. 2012. PMID: 22362358 Review.

10

Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.

van der Hiel B, Blank CU, Haanen JB, Stokkel MP. van der Hiel B, et al. Clin Nucl Med. 2013 Apr;38(4):e182-4. doi: 10.1097/RLU.0b013e3182639765. Clin Nucl Med. 2013. PMID: 23455528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters